Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3 Pt 1
pubmed:dateCreated
2000-10-12
pubmed:abstractText
Fiberoptic bronchoscopy (FOB) may worsen oxygenation and clinical status in severely hypoxemic patients. We conducted a prospective, randomized double-blind trial to compare the delivery of continuous positive airway pressure (CPAP) as a tool for maintaining oxygenation during FOB, to the delivery of oxygen only. Thirty consecutive patients who needed FOB for diagnostic purposes were enrolled. Their arterial oxygen pressure (Pa(O(2))) to inspired oxygen fraction (FI(O(2))) ratio was below 300 mm Hg. CPAP was generated by a simple new device open to the atmosphere. During FOB and the 30 min thereafter, pulse oximetry values (Sp(O(2))) were significantly higher in the CPAP than the Oxygen group (95.7 +/- 1.9% versus 92.6 +/- 3.1, p = 0.02). The lowest Sp(O(2)) values were observed in the Oxygen group (93.5 +/- 2.4% versus 88.6 +/- 3.4, p = 0.002). Arterial blood gases 15 min after FOB showed that Pa(O(2)) had increased in the CPAP group and decreased in the Oxygen group (DeltaPa(O(2)) = +10.5% +/- 16.9 versus -15% +/- 16.6, p = 0.01). Five patients in the Oxygen group, but none in the CPAP group, developed respiratory failure in the 6 h after FOB and required ventilatory assistance (p = 0.03). We conclude that in hypoxemic patients, the use of a new CPAP device during FOB allowed minimal alterations in gas exchange and prevented subsequent respiratory failure.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1073-449X
pubmed:author
pubmed:issnType
Print
pubmed:volume
162
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1063-7
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Continuous positive airway pressure during fiberoptic bronchoscopy in hypoxemic patients. A randomized double-blind study using a new device.
pubmed:affiliation
Pulmonary Department, Medical Intensive Care Unit, and INSERM U 492, Henri Mondor Hospital, AP-HP, University Paris XII, Créteil, France.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial